Skip to main content

stock

PMVP · PMV Pharmaceuticals, Inc.

What PMV Pharmaceuticals, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live PMVP price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on PMVP.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
53,458,058 as of 2026-08-14 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-105.2%
ROA
-91.7%

Health

Current ratio
7.7x
Debt/equity
—

Deep value

NCAV
$70.84M
NCAV per share
$1.33
Price/NCAV
Locked
NNWC
$1.90M
NNWC per share
$0.04
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenue (not reported by this company)Gross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$18.88M-$18.09M
10-Q filed 2026-08-14
2026-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$19.02M-$18.04M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$19.24M-$18.04M
DEF 14A filed 2026-04-22
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$22.52M-$21.06M
10-Q filed 2025-11-12
2025-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$22.88M-$21.21M
10-Q filed 2026-08-14
2025-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$21.56M-$17.44M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$25.17M-$23.19M
DEF 14A filed 2026-04-22
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$21.89M-$19.23M
10-Q filed 2025-11-12
Assets
$82.07M
Equity
$71.50M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$86.21M-$77.74M-$73.61M
2024-12-31—-$85.45M-$58.90M-$51.94M
2023-12-31—-$80.13M-$68.96M-$56.62M
2022-12-31—-$77.04M-$73.32M-$71.74M
2021-12-31—-$58.29M-$57.85M-$47.92M
2020-12-31—-$34.94M-$34.44M-$32.89M
2019-12-31—-$26.64M-$25.35M-$22.17M
2018-12-31—-$18.89M-$17.54M-$15.63M

Company filings

3 offering filings in 12 months

events

  • Executive or director change, Regulation FD disclosure

    Executive or director changeRegulation FD disclosure
    Oct 58-K
  • Material agreement, Other event

    Material agreementOther event
    Sep 18-K
  • Other event

    Other event
    Aug 318-K
  • Results

    Results
    Aug 148-K
  • Shareholder vote results

    Shareholder vote results
    Jun 58-K
  • Results

    Results
    May 128-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named PMVP, and the market events around them.

Sign in to see this

Board

The PMVP board could not be loaded.

Retry the PMVP board

nakagai

Signals on PMVP come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the PMVP board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

PMV Pharmaceuticals, Inc. (PMVP): SEC filings, financials and insider trades · Nakagai